From: Molecular subtyping improves prognostication of Stage 2 colorectal cancer
HR (95% CI) | P | PAge,Sex | PAll | ||
---|---|---|---|---|---|
Age (years) | 60–80 | 2.3 (1.2,4.2) | 0.0002 | 0.0002 | |
80+ | 3.4 (1.7,6.5) | ||||
Male | 1.4 (1.0,1.9) | 0.0640 | 0.0175 | ||
Rectal | 1.5 (1.0,2.1) | 0.0511 | 0.1341 | 0.1341 | |
Right side | 0.9 (0.7,1.3) | 0.5930 | 0.3881 | 0.7978 | |
Lymph node involvement | 1.5 (1.1,2.1) | 0.0139 | 0.0046 | 0.0076 | |
Local recurrence | 2.2 (1.2,4.1) | 0.0187 | 0.0120 | 0.0193 | |
Post-operative metastasis | 3.5 (2.4,5.0) | < 0.0001 | < 0.0001 | < 0.0001 | |
TNM Stage | 2 | 0.8 (0.5,1.3) | 0.0004 | 0.0000 | 0.0015 |
3 | 1.3 (0.8,2.0) | ||||
4 | 3.0 (1.6,5.7) | ||||
CMS | 2 | 1.0 (0.6,1.5) | 0.0949 | 0.2619 | 0.4237 |
3 | 1.4 (0.8,2.6) | ||||
4 | 2.2 (1.1,4.5) | ||||
Unclassified | 1.2 (0.7,2.1) |